The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of ERBB gene fusions (EGFR, ERBB2, ERBB4) across tumor types.
 
Laura Schubert
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Robert Charles Doebele
Employment - Rain Therapeutics
Leadership - Rain Therapeutics
Stock and Other Ownership Interests - Rain Therapeutics
Consulting or Advisory Role - Anchiano; AstraZeneca; Bayer; Blueprint Medicines; Foundation Medicine; GreenPeptide; Guardant Health; Rain Therapeutics; Roche/Genentech; Takeda
Patents, Royalties, Other Intellectual Property - Licensing fees for biologic materials from Black Diamond (Inst); Licensing fees for biologic materials from Foundation Medicine (Inst); Licensing fees for biologic materials from Genentech (Inst); Licensing fees for Biologic Materials from Pearl River (Inst); Licensing fees for Biologic Materials from Voronoi (Inst); Licensing fees for patent from Rain Therapeutics; Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495
Travel, Accommodations, Expenses - Rain Therapeutics; Roche/Genentech
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Hossein Borghaei
Stock and Other Ownership Interests - Rgenix; Sonnet
Honoraria - Amgen; Axiom Biotechnologies; Bristol-Myers Squibb; Celgene; Pfizer
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BioNTech; Boehringer Ingelheim; Bristol-Myers Squibb; Cantargia AB; Celgene; EMD Serono; Genentech; Genmab; HUYA Bioscience International; Lilly; Merck; Novartis; Pfizer; PharmaMar; Regeneron; Rgenix; Sonnet; Takeda; Trovagene
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly; Merck; Novartis
Other Relationship - Incyte; Takeda; University of Pennsylvania
 
Michael J. Demeure
Consulting or Advisory Role - Avant Diagnostics; Bayer; Loxo/Lilly; Orphagen Pharmaceuticals; TD2
(OPTIONAL) Uncompensated Relationships - transmed7
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; IDbyDNA
Honoraria - AACR; Advanced Therapeutics; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; Meyer Consulting; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; Bicara Therapeutics; Gaido; Loxo; Merck; NeoMed; Pfizer; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - Roche
Research Funding - Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - AACR; Advanced Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; LEK; NeoGenomics Laboratories; NeoMed; Roche; Wiley
 
Anh T. Le
No Relationships to Disclose
 
Joshua E. Reuss
Consulting or Advisory Role - OncoCyte
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Genentech/Roche; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Janssen; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Genentech/Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
David R. Braxton
Honoraria - Caris Life Sciences; Caris Life Sciences
Research Funding - Deep Lens
Travel, Accommodations, Expenses - Caris Life Sciences
 
Christian A. Thomas
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Blueprint Medicines; EMD Serono; Jazz Pharmaceuticals; Pfizer
 
Sourat Darabi
Honoraria - OncoLens
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Bayer; D&D Pharmatech; D&D Pharmatech; D&D Pharmatech; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
 
Stephen V. Liu
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; G1 Therapeutics; Genentech; Guardant Health; Inivata; Janssen Oncology; Jazz Pharmaceuticals; Lilly; MSD Oncology; Pfizer; PharmaMar; Regeneron; Takeda
Research Funding - Alkermes (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Debiopharm Group (Inst); Elevation Oncology (Inst); Genentech/Roche (Inst); Lilly (Inst); Lycera (Inst); Merck (Inst); Merus (Inst); Molecular Partners (Inst); Pfizer (Inst); Rain Therapeutics (Inst); RAPT Therapeutics (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Roche/Genentech